Search - tctmd.com

Displaying 161 - 180 of 440

Sort: Relevancy | Date

Presentation ESC 2014

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Presenter: Thomas Pilgrim

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Industry News

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

July 31, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Industry News

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

July 16, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Industry News

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

June 04, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Industry News

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

May 27, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Yael L. Maxwell

May 20, 2014

News Industry News

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

May 15, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

Presentation CIT 2014

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Presenter: Gao Runlin

March 22, 2014

Advertisement

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

Hybrid Revascularization a Promising Option for Diabetic Patients

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content